Genetic Variants in Early-Onset Inflammatory Bowel Disease: Monogenic Causes and Clinical Implications
Authors:
- Duygu Demirtas GunerDGDuygu Demirtas Guner
- Hacer Neslihan BildikHBHacer Neslihan Bildik
- Hulya DemirHDHulya Demir
- Deniz CagdasDCDeniz Cagdas
- Inci Nur Saltik TemizelITInci Nur Saltik Temizel
- Riza Koksal OzgulRORiza Koksal Ozgul
- Hayriye Hizarcioglu GulsenHGHayriye Hizarcioglu Gulsen
- Cagman TanCTCagman Tan
- Begum CicekBCBegum Cicek
- Hasan OzenHOHasan Ozen
- Aysel YuceAYAysel Yuce
- Ilhan TezcanITIlhan Tezcan
Open Access
Abstract
Background/Objectives: This study aims to identify genetic variants associated with early-onset inflammatory bowel disease (IBD) and to improve diagnostic and therapeutic approaches. In selected monogenic IBD cases, treatment included colchicine, interleukin-1 inhibitors, and hematopoietic stem cell transplantation. Methods: This study included patients with early-onset IBD, defined as IBD diagnosed before the age of 10, who were under follow-up at the Department of Pediatric Gastroenterology, Hacettepe University, and agreed to participate between December 2018 and April 2021. Whole-exome sequencing (WES) was performed prospectively in patients without a prior diagnosis of monogenic disease, while clinical and laboratory data were reviewed retrospectively. Identified variants were evaluated for pathogenicity using standard bioinformatics tools. Results: A total of 47 patients were enrolled, including 33 boys (70.2%) and 14 girls (29.8%). The median age at symptom onset was 36 months (IQR: 10–72), and the median age at diagnosis was 3.7 years (IQR: 1.5–7.6). Crohn’s disease was diagnosed in 53.2% (n = 25), ulcerative colitis in 38.3% (n = 18), and unclassified IBD in 8.5% (n = 4). Monogenic IBD was identified in 36.2% (n = 17) of patients, including nine with Familial Mediterranean Fever and others with glycogen storage disease type 1b (n = 2), XIAP deficiency, chronic granulomatous disease, DOCK8 deficiency, IL10 receptor alpha defect, LRBA deficiency, and NFKB2 deficiency (n = 1 each). A novel SLC29A3 gene variant (c.480_481delTGinsCA, p.V161I) (transcript ID: ENST00000479577.2) was identified in 76.6% (n = 36) of patients. Conclusions: This study underscores the importance of genetic variants in early-onset IBD, particularly MEFV and the novel NFKB2. The frequent detection of the SLC29A3 variant may suggest its potential involvement in the pathogenesis of the disease.Keywords
Funding Information
- Hacettepe Üniversitesi (17759)
This publication has 33 references indexed in Scilit:
- Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert CommitteeJournal of Clinical Immunology, 2022
- A Systematic Review of Monogenic Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2022
- The mutational constraint spectrum quantified from variation in 141,456 humansNature, 2020
- Prevalence and Clinical Features of Inflammatory Bowel Diseases Associated With Monogenic Variants, Identified by Whole-Exome Sequencing in 1000 Children at a Single CenterGastroenterology, 2020
- Analysis of protein-coding genetic variation in 60,706 humansNature, 2016
- Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association studyThe Lancet, 2016
- Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populationsNature Genetics, 2015
- NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for ColitisCell, 2011
- A map of human genome variation from population-scale sequencingNature, 2010
- The Association of Inflammatory Bowel Disease and Mediterranean Fever Gene (MEFV) Mutations in Turkish ChildrenDigestive Diseases and Sciences, 2010